Human Chorionic Gonadotropin Market Poised for 8.4 % Growth, Set to Hit $7.32 Billion by 2029

How Is the Human Chorionic Gonadotropin Market Projected to Grow, and What Is Its Market Size?
The market for human chorionic gonadotropin has seen robust growth recently. The projections indicate an increase from $0.95 billion in 2024 to $1.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.7%. The historic growth is driven by factors such as a heightened incidence of hypogonadism among the elderly, heightened awareness of HCG among healthcare professionals and patients, growing popularity of fertility tourism, a rise in the elderly population, and improved affordability and upgrades in healthcare infrastructure.

The market for human chorionic gonadotropin is predicted to witness significant expansion in the forthcoming years, scaling up to $1.42 billion by 2029, with a compound annual growth rate (CAGR) anticipated to be 8.4%. The projected growth during this period is due to the escalating occurrence of infertility, a rising number of polycystic ovary* syndrome cases, growing infertility among women, and amplified utilization of HCG in veterinary medication. The forecast period is also expected to see trends like advancement in the detection of pregnancy, creation of innovative drug formulas, technological applications, commitment to research and development, and product innovation.

What Factors Are Fueling Growth in the Human Chorionic Gonadotropin Market?
The escalating incidence of infertility is set to propel the expansion of the human chorionic gonadotropin market onwards. Infertility implies the incapability to become pregnant despite having regular, unprotected intercourse for at least a year. With more individuals and couples struggling to conceive due to later childbearing, alterations in lifestyle, environmental influences, and medical conditions, the rate of infertility is on the rise. Human chorionic gonadotropin (hCG) is employed in treatments for infertility to prompt ovulation in women and help in the production of testosterone in men, thereby encouraging the release of eggs and enhancing fertility results. For example, the World Health Organization, a intergovernmental organization based out of Switzerland, reported in April 2023 that infertility had affected around 17.5% of the global adult population, translating to roughly one out of every six people worldwide. This underscores the urgent need for affordable, high-class fertility care for those who require it. Consequently, the rising incidence of infertility is fueling the development of the human chorionic gonadotropin market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18638&type=smp

Who Are the Major Industry Players Fueling Human Chorionic Gonadotropin Market Expansion?
Major companies operating in the human chorionic gonadotropin market are Pfizer Inc., Merck & Co Inc., Novartis AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, Janssen Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Menarini Group, Cipla Limited, Hikma Pharmaceuticals plc, Ferring Pharmaceuticals Inc., Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Lupin Limited, Shenzhen Hepalink Pharmaceutical Group Co. Ltd., Scripps Laboratories Inc., Aspen Pharmacare Holdings Limited, Corona Remedies Pvt Ltd., Sanzyme Private Limited, Biocare Medical LLC, Lee BioSolutions Inc., MyBioSource Inc.

Which Key Developments Are Influencing the Human Chorionic Gonadotropin Market?
Leading firms active in the human chorionic gonadotropin market are prioritizing the creation of innovative products, including pregnancy detection kits, to enhance diagnostics precision, improve patient results, and broaden their market presence. Pregnancy detection kits are devices designed to confirm a pregnancy by identifying the existence of human chorionic gonadotropin (hCG) in an individual's body. For example, in June 2022, Proov, a US-based manufacturer of medical equipment, introduced new hCG tests specifically designed for early pregnancy detection. This allows women to check their pregnancy status up to six days prior to their anticipated period. These tests work by detecting the presence of human chorionic gonadotropin (hCG) in the urine and are over 99% reliable. This innovation is aimed at providing a trustworthy and readily available approach for women to track their pregnancy status earlier than conventional tests, enabling them to make educated choices about their reproductive health.

How Is the Segmentation of the Human Chorionic Gonadotropin Market Defined?
The human chorionic gonadotropin market covered in this report is segmented -

1) By Technology: Natural Source Extraction, Recombinant Technology
2) By Therapeutic Area: Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Other Therapeutic Areas
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End User: Fertility Clinics, Research Institutions, Other End Users

Subsegments:
1) By Natural Source Extraction: Extraction From Pregnant Women's Urine, Extraction From Animal Sources
2) By Recombinant Technology: Recombinant Hcg, Recombinant Hcg For Therapeutic Use, Recombinant Hcg For Diagnostic Applications

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report

What Is the Leading Region in the Human Chorionic Gonadotropin Market?
North America was the largest region in the human chorionic gonadotropin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Human Chorionic Gonadotropin Global Market Report?

- Market Size Analysis: Analyze the Human Chorionic Gonadotropin Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Human Chorionic Gonadotropin Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Human Chorionic Gonadotropin Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Human Chorionic Gonadotropin Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18638

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.